Loperamide therapy for acute diarrhea in children: Systematic review and meta-analysis

被引:79
作者
Li, Su-Ting T. [1 ]
Grossman, David C.
Cummings, Peter
机构
[1] Univ Calif Davis, Dept Pediat, Sacramento, CA 95817 USA
[2] Grp Hlth Cooperat Puget Sound, Dept Prevent Care, Seattle, WA USA
[3] Grp Hlth Cooperat Puget Sound, Ctr Hlth Studies, Seattle, WA USA
[4] Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA
[5] Univ Washington, Dept Pediat, Seattle, WA 98195 USA
[6] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA
来源
PLOS MEDICINE | 2007年 / 4卷 / 03期
关键词
D O I
10.1371/journal.pmed.0040098
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Loperamide is widely used in adults for acute diarrhea. However, its use in children has been discouraged by the World Health Organization and the American Academy of Pediatrics owing to concerns over safety and efficacy in young children. Methods and Findings To assess the efficacy and adverse effects of loperamide compared with placebo for acute diarrhea in children, we reviewed Medline, EMBase, the Cochrane Central Register of Controlled Trials, and bibliographies of known clinical trials and of review articles, and we also interviewed key investigators in the field. We undertook a systematic review and meta-analysis of randomized controlled trials of children younger than 12 y of age with acute diarrhea, comparing loperamide with placebo. Included trials reported data on diarrhea duration or severity, or provided data on adverse effects. Compared with patients who received placebo, patients allocated to loperamide were less likely to continue to have diarrhea at 24 h (prevalence ratio 0.66, 95% confidence interval [CI]: 0.57 to 0.78), had a shorter duration of diarrhea by 0.8 d (95% CI: 0.7 to 0.9 d), and had a lower count of stools at 24 h (0.84, 95% CI: 0.77 to 0.92). Results were similar when random-effects summaries were estimated. Serious adverse events, defined as ileus, lethargy, or death, were reported in eight out of 927 children allocated to loperamide (0.9%, 95% CI: 0.4% to 1.7%). Serious adverse events were not reported in any of the 764 children allocated to placebo (0%, 95% CI: 0% to 0.5%). Among the children allocated to loperamide, serious adverse events were reported only among children younger than 3 y. Conclusions In children who are younger than 3 y, malnourished, moderately or severely dehydrated, systemically ill, or have bloody diarrhea, adverse events outweigh benefits even at doses <= 0.25 mg/kg/d. In children who are older than 3 y with no/minimal dehydration, loperamide may be a useful adjunct to oral rehydration and early refeeding.
引用
收藏
页码:495 / 505
页数:11
相关论文
共 32 条
  • [1] ANDERSON J, 1984, Advances in Therapy, V1, P14
  • [2] [Anonymous], 2001, Systematic Reviews in Health Care: Meta-Analysis in Context
  • [3] Acute diarrhea: A practical review
    Aranda-Michel, J
    Giannella, RA
    [J]. AMERICAN JOURNAL OF MEDICINE, 1999, 106 (06) : 670 - 676
  • [4] BOULLOCHE J, 1994, ANN PEDIATR-PARIS, V41, P457
  • [5] BOWIE MD, 1995, S AFR MED J, V85, P885
  • [6] BRADBURN MJ, 1998, STATA TECH B, V44
  • [7] CHAPOY P, 1983, MED CHIR DIG, V12, P619
  • [8] CHAVARRIA A P, 1984, Advances in Therapy, V1, P115
  • [9] Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986
  • [10] CORDIER MP, 1987, ANN PEDIATR-PARIS, V34, P653